Confirmatory Results about Spironolactone (S) Effects on AASI in Essential Hypertensive Patients: Short Communication
In this short communication we report complementary data to previous ones, which confirm the effects of spironolactone in reducing AASI, a marker of arterial stiffness, in essential hypertensive patients after 6 months of treatment.
2021 ◽
Vol 8
(3)
◽
pp. 01-02
2005 ◽
Vol 12
(3)
◽
pp. 183
Keyword(s):
2018 ◽
Vol 41
(7)
◽
pp. 670-674
2021 ◽
Vol 39
(Supplement 1)
◽
pp. e114-e115
Keyword(s):